MEPSGEN launches small-volume NanoCalibur Mini nanoparticle formulation system
Company / institutional announcement · MEPSGEN US / PR Newswire
Source published:
Site published: 2026-11-03 · Updated: 2026-11-03
This source is linked automatically. Choose a question to get started.
What changed
MEPSGEN has launched NanoCalibur Mini for automated formulation of lipid and polymeric nanoparticles at volumes of 0.1 to 3 milliliters. The system targets early screening when payloads and excipients are scarce. The company says its platforms retain identical microfluidic mixing geometry across scales and increase throughput through parallelization, an approach intended to reduce process redevelopment during technology transfer.
Why it may matter
Low-volume screening can conserve expensive payloads, but transfer to GMP still requires evidence on particle size, encapsulation, and batch consistency.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections